| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fallon John A. | Director | C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON | /s/ Colleen Tupper as Attorney-in-Fact for John A. Fallon, MD | 14 Nov 2025 | 0001560152 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | COLL | Common Stock | Options Exercise | $247K | +15K | +23.21% | $16.49 | 79.6K | 12 Nov 2025 | Direct | |
| transaction | COLL | Common Stock | Options Exercise | $185K | +19.9K | +24.93% | $9.33 | 99.5K | 12 Nov 2025 | Direct | |
| transaction | COLL | Common Stock | Sale | -$1.65M | -34.9K | -35.03% | $47.21 | 64.6K | 12 Nov 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | COLL | Stock Option (Right to Purchase) | Options Exercise | $0 | -15K | -100% | $0.00 | 0 | 12 Nov 2025 | Common Stock | 15K | $16.49 | Direct | F2 |
| transaction | COLL | Stock Option (Right to Purchase) | Options Exercise | $0 | -19.9K | -100% | $0.00 | 0 | 12 Nov 2025 | Common Stock | 19.9K | $9.33 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option is fully vested and exercisable. |